Table 1.
Demographics by glutamine and placebo group
| Characteristics | Allb (n = 56) | Glutamine (n = 24) | Placebo (n = 25) | p |
|---|---|---|---|---|
| Gender | NS | |||
| Female | 29 | 14 | 12 | |
| Male | 27 | 10 | 13 | |
| Age (years)a | NS | |||
| Median | 11.0 | 11.0 | 10.0 | |
| Range | 4.0–19.0 | 5.0–19.0 | 4.0–17.0 | |
| Race | NS | |||
| White | 15 | 6 | 8 | |
| Black | 7 | 2 | 4 | |
| Hispanic | 30 | 15 | 12 | |
| Other | 4 | 1 | 1 | |
| Diagnosis | NS | |||
| ALL | 33 | 13 | 16 | |
| Non-Hodgkin Lymphoma | 2 | 0 | 1 | |
| Lymphoma | 1 | 1 | 0 | |
| Ewing Sarcoma | 3 | 2 | 1 | |
| Wilms’ Tumor | 5 | 1 | 3 | |
| Rhadomyosarcoma | 6 | 4 | 2 | |
| Other | 6 | 3 | 2 |
NS not statistically significant at 0.05 level
a
Age at date of consent
b
Including seven patients who were removed from study prior to randomization or completion of the 3 time points